JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
- PMID: 35283400
- DOI: 10.1253/circj.CJ-20-1212
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Comment in
-
JCS/JHRS Guideline: Rivaroxaban Not Recommended for Patients With Nonvalvular Atrial Fibrillation and High Bleeding Risk.Circ J. 2022 Jun 24;86(7):1204. doi: 10.1253/circj.CJ-22-0146. Epub 2022 May 27. Circ J. 2022. PMID: 35644537 No abstract available.
-
JCS/JHRS Guideline: Rivaroxaban Not Recommended for Patients With Nonvalvular Atrial Fibrillation and High Bleeding Risk - Reply.Circ J. 2022 Jun 24;86(7):1205. doi: 10.1253/circj.CJ-22-0285. Epub 2022 May 27. Circ J. 2022. PMID: 35644538 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical